Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
for Obesity & Overweight
13 locations incl. Phoenix
Sponsor: Veru Inc.
Sex: All·Age: 65 - 100
Code: NCT07446998·Phase 2·Recruiting·Listed Mar 2026